OT-551

N/A

Report date: 2022/11/25 17:43:15
NME

Base Information

Drug NameOT-551
Drug Alias NameOT-551CPC-551
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsRetinal PerforationsGeographic AtrophyMacular Degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesColby Pharmaceutical Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)Othera Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsRetinal PerforationsGeographic AtrophyMacular Degeneration +[4] 

Other Information

ATC CodeN/A
Related LinksDrugBank